BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12886712)

  • 41. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
    Ganapati R; Revankar CR; Pai VV; Kingsley S
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):308-9. PubMed ID: 10575413
    [No Abstract]   [Full Text] [Related]  

  • 44. Autochthonous leprosy in metropolitan France presenting with a diffuse infiltration of the face and febrile illness.
    Ezzedine K; Malvy D; Beylot C; Longy-Boursier M
    Int J Dermatol; 2009 Jan; 48(1):69-72. PubMed ID: 19126055
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
    Kumar A; Girdhar A; Girdhar BK
    Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
    Shetty VP; Wakade A; Antia NH
    Lepr Rev; 2001 Sep; 72(3):337-44. PubMed ID: 11715280
    [No Abstract]   [Full Text] [Related]  

  • 47. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
    Rea TH
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
    Villahermosa LG; Fajardo TT; Abalos RM; Cellona RV; Balagon MV; Dela Cruz EC; Tan EV; Walsh GP; Walsh DS
    Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An 8-12 year follow-up of highly bacillated Indian leprosy patients treated with WHO multi-drug therapy.
    Desikan KV; Sundaresh P; Tulasidas I; Rao PV
    Lepr Rev; 2008 Sep; 79(3):303-10. PubMed ID: 19009979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclosporin A treatment in reversal reaction.
    Chin-A-Lien RA; Faber WR; Naafs B
    Trop Geogr Med; 1994; 46(2):123-4. PubMed ID: 8079388
    [No Abstract]   [Full Text] [Related]  

  • 51. Dapsone-induced motor polyneuropathy in a patient with leprosy.
    Pavithran K; Satish TC
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):262-3. PubMed ID: 9251603
    [No Abstract]   [Full Text] [Related]  

  • 52. A case of relapsed borderline-lepromatous (BL) leprosy following 27 months of multiple drug therapy, Bhutan.
    Reimer DE; Andersen SM
    Lepr Rev; 1995 Jun; 66(2):183. PubMed ID: 7637531
    [No Abstract]   [Full Text] [Related]  

  • 53. Clofazimine: new products. Major antileprous drug.
    Prescrire Int; 1999 Apr; 8(40):44-6. PubMed ID: 10848059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
    Norman G; Joseph G; Richard J
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):1-7. PubMed ID: 15217321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A man with facial changes.
    Mirfazaelian H; Eilami O; Afzalimoghadam M; Daneshbod Y
    Br J Hosp Med (Lond); 2014 Nov; 75(11):656. PubMed ID: 25383440
    [No Abstract]   [Full Text] [Related]  

  • 56. [Leprosy].
    Ishii N; Sasaki S
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():531-5. PubMed ID: 12722275
    [No Abstract]   [Full Text] [Related]  

  • 57. Lucio's leprosy: a clinical and therapeutic challenge.
    Jurado F; Rodriguez O; Novales J; Navarrete G; Rodriguez M
    Clin Dermatol; 2015; 33(1):66-78. PubMed ID: 25432812
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leprosy and HIV co-infection in five patients.
    Trindade MA; Manini MI; Masetti JH; Leite MA; Takahashi MD; Naafs B
    Lepr Rev; 2005 Jun; 76(2):162-6. PubMed ID: 16038250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rifampicin-induced erythema nodosum leprosum-like eruption in borderline lepromatous leprosy.
    Karthikeyan K; Thappa DM; Kadhiravan T
    Indian J Lepr; 2001; 73(2):167-9. PubMed ID: 11579653
    [No Abstract]   [Full Text] [Related]  

  • 60. Relapses in multibacillary leprosy patients after multidrug therapy.
    Poojabylaiah M; Marne RB; Varikkodan R; Bala N; Dandakeri S; Martis J
    Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.